Russian and international news and events in the field of pharmacy
Kaluga Pharmaceutical Cluster: First Russian Cluster to Get ESCA Cluster Excellence Silver Certificate
On October 24-26, 2017 European Secretariat for Cluster Analysis (ESCA) experts visited Kaluga Pharmaceutical Cluster to audit the cluster management system and evaluate the cluster’s business activities on the basis of 30 key indicators.
The Ministry of Industry and Trade of the Russian Federation Issues License for Medicines’ Production to Novo Nordisk
On September 4, 2017 the Ministry of Industry and Trade of the Russian Federation issued a license to produce insulin finished dosage forms at Novo Nordisk OOO production facility in Grabtsevo industrial park, Kaluga Region. This is a major step in expansion of Novo Nordisk modern insulin production.
AstraZeneca begins manufacturing of the first targeted drug for lung cancer treatment in Russia
On September 8, international biopharmaceutical company AstraZeneca launched a new high-tech production process at its plant at Vorsino industrial park in Kaluga Region. One of the first drugs to be manufactured on the new line is osimertinib – an innovative targeted drug for treatment of lung cancer.
The joint decision of questions of preparation and retraining of personnel, participation in educational projects of GK "ROSNANO"
The creation and development of service competencies common to all cluster members
The presence of a uniform and understandable for all participants of the development strategy until 2020
Consolidated participation in government programs for the development of territorial and industrial clusters, the representation and protection of interests of participants in the Federal and regional authorities
C.H.I.CO. Cluster of Health, Innovation and Community